We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




Samsung Plunges into the Medical Device Market

By LabMedica International staff writers
Posted on 07 Oct 2010
A 19-panel blood-testing gadget that is smaller, quicker, and less expensive than current hospital-targeted offerings represents the Samsung (Seoul, Republic of Korea) debut into the world of medical devices. More...


The Samsung IVD-A10A measures levels of blood glucose, cholesterol levels, and 17 other substances in the blood used in the diagnosis of heart, liver, and kidney diseases. Future additional accessories will be used to perform cancer marker immunoassays and diagnose infectious diseases, based on clinical chemistry tests of various metabolites. According to the company, the device takes only 12 minutes to complete a standard blood test, compared to two to three days with traditional equipment. Samsung, which developed the product following a four year, US$245-million investment, will partner with Choongwae Pharma Corporation (Seoul, South Korea), a major Korean pharmaceutical manufacturer, to exclusively sell the device to hospitals throughout the country.

The new device is Samsung's first move into the medical equipment market, representing a commitment to invest $9.85 billion in the healthcare business by 2020, with the goal of achieving $8.34 billion in annual sales that year. Samsung sees medical equipment as one of five new growth drivers for the company, along with solar cells, rechargeable cells for hybrid electric vehicles, light emitting diode (LED) technologies, and biopharmaceuticals, all intended to eventually reduce the company's reliance on the production of TV's, cellular phones, memory chips, and displays.

Related Links:

Samsung
Choongwae Pharma Corporation



Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
New
Gold Member
Fully-auto Specific Protein (Nephelometry) Analyzer
PA240
New
Next-Generation Sequencing Platform
AXELIOS 1 Platform
Platinum Member
Integrated Biochemical & Immunological System
Biolumi CX Solution X10+C10
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The Xpert Hemorrhagic Fever Panel test runs on Cepheid’s GeneXpert Dx systems (Photo courtesy of Cepheid)

WHO Emergency Listing Supports Rapid Molecular Testing for Ebola Outbreak Response

The Democratic Republic of the Congo is confronting an Ebola Bundibugyo outbreak that the World Health Organization (WHO) designated a Public Health Emergency of International Concern on May 17, 2026.... Read more

Microbiology

view channel
Image Credit: Adobe Stock

Gut Microbiome Classifier Improves Colorectal Cancer Risk Stratification

Colorectal cancer remains a leading cause of cancer mortality, and current noninvasive screening methods still miss many precancerous lesions. Clinicians therefore need tools that improve risk stratification... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.